DHR vs VLTO
DHR: Danaher is a diversified conglomerate providing scientific instruments, diagnostics, and industrial solutions across life sciences, environmental monitoring, product identification, and healthcare globally. VLTO: Veralto provides mission-critical water quality and product identification technology solutions that enable essential operations for a wide range of global industries.
Side-by-side fundamentals
| Metric | DHR | VLTO | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $217.46 | $96.48 | |
| Market cap | $152.9B | $23.7B | |
| P/E as of 2026-10-08 | 38.61 | 24.32 | VLTO lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 7.82 | |
| Net margin FY2025, SEC XBRL | +14.7% | +17.1% | VLTO higher |
| Gross margin FY2025, SEC XBRL | +59.1% | +59.9% | VLTO higher |
| Operating margin FY2025, SEC XBRL | +19.1% | +23.2% | VLTO higher |
| ROE FY2025, SEC XBRL | +6.9% | +30.3% | VLTO higher |
| ROA FY2025, SEC XBRL | +4.3% | +12.2% | VLTO higher |
| Debt / equity as of 2026-09-03 | 0.51 | 1.09 | DHR lower |
| Revenue growth (YoY) as of 2026-09-03 | +4.6% | +6.2% | VLTO higher |
| Revenue CAGR (3y) SEC XBRL | -2.7% | +4.2% | VLTO higher |
| Dividend yield as of 2026-09-03 | +0.8% | +0.6% | DHR higher |
| Beta as of 2026-09-03 | 0.78 | 0.56 | |
| 1-year return as of 2026-10-08 close | +6.1% | -7.2% | DHR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.